Sign up to access all valuation multiples
Topcon Corp sells ophthalmic instruments, medical equipment, machine control systems, and GPS-related products. Its operations are structured around three main areas: the Positioning Business, Eye Care Business, and Other. The Positioning division handles products such as total stations, 3D laser scanners, ICT automated construction systems, IT agricultural systems, GNSS receivers for surveying, laser equipment, and software for construction and civil engineering. The Eye Care division provides 3D fundus imaging devices, fundus cameras, auto and kerato refractors, slit lamps, tonometers, lens meters, ophthalmic laser systems, and related software for image management and electronic medical records.
1932
5.3K+
LTM Revenue $1.5B
LTM EBITDA $169M
$2.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Topcon has a last 12-month revenue (LTM) of $1.5B and a last 12-month EBITDA of $169M.
In the most recent fiscal year, Topcon achieved revenue of $1.5B and an EBITDA of $130M.
Topcon expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Topcon valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | $781M | XXX | $768M | XXX | XXX | XXX |
| Gross Margin | 53% | XXX | 53% | XXX | XXX | XXX |
| EBITDA | $169M | XXX | $130M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 9% | XXX | XXX | XXX |
| EBIT | $68.9M | XXX | $59.5M | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $20.4M | XXX | $2.8M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $423M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 29, 2025, Topcon's stock price is JPY 3294 (or $22).
Topcon has current market cap of JPY 347B (or $2.3B), and EV of JPY 428B (or $2.9B).
See Topcon trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.9B | $2.3B | XXX | XXX | XXX | XXX | $0.19 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 29, 2025, Topcon has market cap of $2.3B and EV of $2.9B.
Topcon's trades at 2.0x EV/Revenue multiple, and 21.7x EV/EBITDA.
Equity research analysts estimate Topcon's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Topcon has a P/E ratio of 114.9x.
See valuation multiples for Topcon and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| EV (current) | $2.9B | XXX | $2.9B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 17.0x | XXX | 21.7x | XXX | XXX | XXX |
| EV/EBIT | 41.8x | XXX | 45.4x | XXX | XXX | XXX |
| EV/Gross Profit | 3.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 114.9x | XXX | 224.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -116.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTopcon's last 12 month revenue growth is 4%
Topcon's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Topcon's rule of 40 is 13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Topcon's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Topcon and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | 21% | XXX | 28% | XXX | XXX | XXX |
| Rule of 40 | 13% | XXX | 13% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 21% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 49% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Topcon acquired XXX companies to date.
Last acquisition by Topcon was XXXXXXXX, XXXXX XXXXX XXXXXX . Topcon acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Topcon founded? | Topcon was founded in 1932. |
| Where is Topcon headquartered? | Topcon is headquartered in Japan. |
| How many employees does Topcon have? | As of today, Topcon has 5.3K+ employees. |
| Who is the CEO of Topcon? | Topcon's CEO is Mr. Takashi Eto. |
| Is Topcon publicy listed? | Yes, Topcon is a public company listed on TKS. |
| What is the stock symbol of Topcon? | Topcon trades under 7732 ticker. |
| When did Topcon go public? | Topcon went public in 1949. |
| Who are competitors of Topcon? | Similar companies to Topcon include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Topcon? | Topcon's current market cap is $2.3B |
| What is the current revenue of Topcon? | Topcon's last 12 months revenue is $1.5B. |
| What is the current revenue growth of Topcon? | Topcon revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Topcon? | Current revenue multiple of Topcon is 2.0x. |
| Is Topcon profitable? | Yes, Topcon is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Topcon? | Topcon's last 12 months EBITDA is $169M. |
| What is Topcon's EBITDA margin? | Topcon's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Topcon? | Current EBITDA multiple of Topcon is 17.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
